Description: Summary of research from the Initiative 18/11 - Pharmacy team about the drug development process for traditional pharmaceuticals: Who does the research and discovery? What does the research and discovery process entail? How are targets identified and validated for research and discovery? What are clinical trials and how are they conducted? How is the drug development process regulated? How is the drug development process funded?

Description: This discussion looks at Group Accident and Sickness Insurance and asks the following questions: What loss ratios are expected during 1960 and 1961 under newly determined premium rates for basic medical care, supplementary major medical and comprehensive major medical insurance coverages? What are the design trends under comprehensive major medical insurance coverages? From Transactions of Society of Actuaries 1960, Vol. 12, No. 34.

Description: Discussion of recent developments in the taxation of noncoordinated benefits such as fixed indemnity, hospital indemnity, and specified disease insurance policies. Developments include a recent Chief Counsel Advice Memorandum and proposed triagency rulemaking that would impact non coordinated benefits.

Description: This discussion focuses on Group Accident and Health Insurance, particularly, is there a solution to continually revising rates, what are the advantages and disadvantages of rates that vary by area, and on what size cases is the loss ratio with the previous carrier sought? From Transactions of Society 1960, Vol. 12, No. 33.

Description: Stale portfolio got your sales down? In this session, you'll learn about the latest and greatest in product development trends and innovations which you can use to refresh and revitalize your products. At the conclusion of this session, attendees will have a better understanding on market trends in product development as well as leading innovations.